Idarucizumab Shows Reliable Reversal of Dabigatran

This article originally appeared here.
Share this content:
Idarucizumab Shows Reliable Reversal of Dabigatran
Idarucizumab Shows Reliable Reversal of Dabigatran

THURSDAY, July 13, 2017 (HealthDay News) -- Idarucizumab can reverse the anticoagulant effect of dabigatran in emergency situations, according to a study published online July 11 in the New England Journal of Medicine. The research was published to coincide with the International Society on Thrombosis and Haemostasis Congress, held from July 8 to 13 in Berlin.

Charles V. Pollack Jr., M.D., from Thomas Jefferson University in Philadelphia, and colleagues performed a multicenter open-label study to examine whether 5 g of intravenous idarucizumab would be able to reverse the anticoagulant effect of dabigatran in 503 patients with uncontrolled bleeding (group A, 301 patients) or who were about to undergo an urgent procedure (group B, 202 patients).

The researchers found that 45.5 and 32.6 percent of patients in group A presented with gastrointestinal bleeding and intracranial hemorrhage; the median time to bleeding cessation was 2.5 hours. The median time to initiation of the intended procedure was 1.6 hours in group B; in 93.4, 5.1, and 1.5 percent of patients, periprocedural hemostasis was assessed as normal, mildly abnormal, and moderately abnormal, respectively. At 90 days, thrombotic events occurred in 6.3 and 7.4 percent of patients in groups A and B, respectively, and the corresponding mortality rates were 18.8 and 18.9 percent. No serious adverse safety signals were observed.

"In emergency situations, idarucizumab rapidly, durably, and safely reversed the anticoagulant effect of dabigatran," the authors write.

The study was funded by Boehringer Ingelheim, the manufacturer of idarucizumab.

Abstract
Full Text
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

NTproBNP Levels Are Significantly Lower in Blacks

NTproBNP Levels Are Significantly Lower in Blacks

Higher NTproBNP levels linked to increased risk of death; this association did not differ by race

Data May Weigh on Pros/Cons of Expanded Care Optometry

Data May Weigh on Pros/Cons of Expanded Care ...

Majority of residents in Kentucky, Oklahoma, New Mexico live within 30 minutes of ophthalmologist

Gaps Seen Between Hearing Loss, Receipt of Medical Evaluation, Tx

Gaps Seen Between Hearing Loss, Receipt of Medical ...

About 20.6 percent of those with hearing less than excellent/good had visited doctor for hearing issues

is free, fast, and customized just for you!

Already a member?

Sign In Now »